A 2024 meta-analysis in Infection Control and Hospital Epidemiology confirmed that antiseptic barrier caps significantly reduce infection rates, particularly in ICUs, and found them highly cost-effective with median savings of $21,890 per CLABSI prevented.

, several high-quality research papers and clinical summaries highlight their effectiveness in reducing hospital-acquired infections and saving costs. Key Research & Clinical Papers

If you are looking for evidence to support buying or implementing 3M Curos Disinfecting Caps Go to product viewer dialog for this item.